JFIFRPhotoshop 3.08BIM6?Randomized Trial Tests Losartan and Prednisolone for Post-COVID720260801PSCIENMAGUAuthoraRandomized Trial Tests Losartan and Prednisolone for Post-COVID Syndrome and Cardiac Inflammation Science@https://scienmag.com/randomized-trial-tests-losartan-and-prednis© 2026 Sciencehttps://scienmag.com/The long shadow cast by COVID-19 is moving deeper into the territory of cardiovascular medicine. A randomized, double-blind, placebo-controlled trial published in Nature Communications examines whether two established drugs—losartan and prednisolone—can influence post-COVID syndrome and signs of cardiac inflammation. The study, led by Victor O. Puntmann, Eike Nagel and colleagues, addresses a question that has […]ScienceMedMedicineMedicine(corticosteroids in long COVID management!COVID-19 and cardiac inflammation0effects of losartan on post-viral cardiac damage#immune dysregulation after COVID-19"long COVID cardiovascular symptoms$losartan for post-COVID inflammation/non-pharmaceutical interventions for long COVID.persistent inflammation in post-COVID patientsPost-COVID syndrome treatment$prednisolone for long COVID symptoms$Randomized controlled trial COVID-19(vascular damage and clotting in COVID-19C    !'"#%%%),($+!$%$C   $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$"C!1QAa"2q#R3BScr$D%456bs:!1AQ"a2Rq#345S ?=wan;LqycR{VۛVyGNBGfy%"Ås UE˹v^j^kBƊT:偲 9;ξ=k4Uϕ}[AֳZ j/dD5bM=Ա×8PǣN\V0=^)*VEO>\/vyH%\ξ@+4K|;trzA?v39ht[rJ6ibtь-ŧ<"qy~sd6Y߅ᔀ S83'6Ux{7R@,#ѨJI z[[K&/٪->⊄) $gp~o[-|ƭuZT{P@4?\l>NU:êX\ZaM BV0h$_7TZ$]aFa,LZt6 #$!TjPow7m&!ĩ§HB6ˮ저m}Qp1ekM/F9J0bDZؾh\.x'>71M5&;3AUUpet@ċ*TRAJ[W5܅dL-[;C@@q nqMSQ;n$]B [Z6 ;viW886$SkP=4XJ-qp+K-7LJ mZoJ΍rԸo) (VR6;u%+BB"1.eFKz(ʜz^${\^p}?a*lozȰCTBGA(gʩÉQ!t 61Hju^;HmIZ\JҢ~ڍQ[  Yd 쫪xYe&%*eagp>gcUv.zGuqCNr`7yWtKk.!@ܐzOAuv@kW[!GZJ:{vcsZ G7ΐ~t!CuMi|I+#=i<נ\ efFl碴Ĕ}Ά׌F3oփpT݃P6u @ßUnө-Ŏ j\;xFG>;++$4Tp*4nHtjݤ杠`FBP=Ӗ!fjo@Khn+u~jQh^RNfZ$%;Szi),R}}_k4M *}Էʴhh7x Ƒ)JzB8ooK6{9*1G j$ q;O5*ccQF$Oꬄ2.ruyO*:bZ$b; վCzec+էTenR~TWCq2mHP2n͗$?:뎾b Iwmm+P ] H ҴӶݳjovRF$r 1MԾ8hz$⃿ [:׵}mVڞm?3KTGnd8ӏ4egTū68oE -TR=w9QD*d.:|#$gbi^KJzEWs'}[\uH/2QZ(9[V-K*\Nr3排| ܨ/ѯ8]%x y k S]$h[I|Np iqܝs:RGI߮I2'|\}U(gT,h[Q3]c]oEKÈs12Ռ2+-ȱdG,`{+,Hg #8#cN5h:Xlvz:(ߔsY>Uyh ihic.#|zթkĸp@k~kq.!(PKM0Jz Vh;c%i<0m;mkIr!Uڷښti˚Si^V:]bm@#>b4͞ʚoaq*_w?Zj67V5s{IMm-J\-?,V%S4[tX\փ`?xM@WlCNx!䴁V<WRp1RTtPiNE$P+fiBQu?%uĠw&Ē#<m˪ʽWԯ1C-Z@;o}0;sCgaJ743r#cj%R1>iCA\z;fw2f{ldop'(_ZJbr;!!g$٥8y3X5nA#;ZeI˚mKn-D1R@40aE}Ǿ3Rבu{T᥮8 z2&K~*BI(w޵όL97 HP!!)HHHgJL.npUZI$%͌A *%8P}|T(,Ҫq^^C1ӶGAz I$*-HG(mC?vW|/YkXMƭ̴IBX]4{j.4#9N櫚dFnZl^ >$s#~1OU/U8Iܧ-`Fu *@6f$2Q|mpmJmm9(N{e-net\.} M"4rK3\.*וZrR6V^ ?1\jلjA]mwH !Uq},t!/%j|O"R1HՏΐyIL7Fr8j|kXs XWiR/cQ+md!/NY$(dn*+œ 2H$lvGbkhzd6 !) `6+]nq-AheKQd1qMW.XQoǠ&-( qkSaV\Bu%ntJzEj;6|feĢZ_fpj_^Յs?tǢn':K%h(ikfGKhSc]rR$EZRTҷA~T$鿕zgcS D==$-^-}ʴ+bVTBcwx0,t{wWNL]q߯1PmLu?])u~oŀs,g;/΀3xk@ڗ*ZV \|qerC~kB.Wʶ[+J,qg`Or;u\Mo4ZFup&K9(!((jY#: G9ǖSs VOJv+mlm gcIId4SJ4d%C->}@bTDTU dbhg+ 'Q_ވ ҭhuz)bη#S$ZF[Kd?1a^lSj*'MSk]ْY.x+@!_Nid 7VmCaRVph/#P OKϲ Xo=Vs{m^«UF[lϠ3*dܔy*N{rqTf}!-MO`Ur=ŏCU]-;+ax5s@1}R"sP8z(g+#zu`L90[~1qS$W6kHx6vTyqCn~Up K˫.KzG^uwRv\Xk'puY_63'KYܩI=8iY[b?"JTyzTNb"Җ<) =|a&Z\a~ysWԴ0G`#z1!iofJ>Bk3 Wt4l8ֹRu$; %͡pMRӹJ3V}PFx5Ji Abj-6_id ;#,U|3IҰ썭H^tfTv_F[T=;g$N$^=$GW ay گ Ҕ[6}l\UP?WGļrz&*5 M$a)RNNv?1VQUvJ.kC*8L4͖僑Ue RT'ŕַҙC̸ T(^;f5s)".ER#7U/ft ~uv9i#~;ڬ:4h!F7*zN>S+ܠϗUwQ>g9NfH r*?S[mΆHJV| ;T'S:%~zHCB򨾥Z\eZ׸W kq1 'b*o* gV?T7,|y?(5KAK>Hi u?[ʏŒUwD)Σ=*ؐq!'Uw4sa^kvb4 ؕLKJa&N*UnuV]q8h ZJRL*T2Rjп*[gWڕ*i *WRyyb3/(RvEg 0+**Hgu(m[gz+dX=Rru=;TR